BDTX Black Diamond Therapeutics
Health Care, filed as BLACK DIAMOND THERAPEUTICS I (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
Insider trades
Open-market buys and sales by BDTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- None no planned (10b5-1) sales
No open-market buys or sales on file.
Also filed in the last 12 months, not counted as buying or selling: 8 stock grants.
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $134.03M | $101.18M | $132.44M |
| Total non-current assets * | $24.53M | $21.46M | $10.57M |
| Total assets | $158.57M | $122.64M | $143.01M |
| Total current liabilities | $19.65M | $20.57M | $15.73M |
| Total non-current liabilities * | $22.18M | $18.78M | $15.07M |
| Total equity | $116.74M | $83.28M | $112.21M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.